Cite
HARVARD Citation
Ghorani, E. et al. (2017). Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet. 390 (10110), pp. 2343-2345. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ghorani, E. et al. (2017). Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet. 390 (10110), pp. 2343-2345. [Online].